Just six U.S. medical schools earned an A from the American Medical Student Association in the groups 2007 PharmFree Scorecard, which ranks medical schools according to their pharmaceutical influence policies. The AMSA introduced the PharmFree campaign in 2002 to educate and train medical students to act professionally and ethically with the pharmaceutical industry. For 2007, Stanford University School of Medicine, the University of California at Davis School of Medicine, the University of Michigan Medical School, the University of Pennsylvania Medical School, the University of Vermont College of Medicine and Yale University School of Medicine all received As, which means those schools have a comprehensive policy that restricts pharmaceutical company representatives access to both the medical school campuses and the academic medical center.
It is important that we work to keep our medical schools and teaching hospitals free of the influence of pharmaceutical companies, Jay Bhatt, national president of the AMSA, said in a news release last month. PharmFree medical students become PharmFree doctors, and that commitment to evidence-based medicine benefits our patients and our colleagues. Data for the 2007 scorecard were collected in September and October 2006.
Established in 1950, the AMSA is a student-governed, not-for-profit organization that represents more than 68,000 members, including medical and premedical students, residents and practicing physicians.